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Abstract
Much of the evolution of human behavior remains a mystery, including how certain disad-
vantageous behaviors are so prevalent. Nicotine addiction is one such phenotype. Several
loci have been implicated in nicotine related phenotypes including the nicotinic receptor
gene clusters (CHRNs) on chromosomes 8 and 15. Here we use 1000 Genomes sequence
data from 3 populations (Africans, Asians and Europeans) to examine whether natural
selection has occurred at these loci. We used Tajima’s D and the integrated haplotype
score (iHS) to test for evidence of natural selection. Our results provide evidence for strong
selection in the nicotinic receptor gene cluster on chromosome 8, previously found to be sig-
nificantly associated with both nicotine and cocaine dependence, as well as evidence selec-
tion acting on the region containing the CHRNA5 nicotinic receptor gene on chromosome
15, that is genome wide significant for risk for nicotine dependence. To examine the possi-
bility that this selection is related to memory and learning, we utilized genetic data from the
Collaborative Studies on the Genetics of Alcoholism (COGA) to test variants within these
regions with three tests of memory and learning, the Wechsler Adult Intelligence Scale
(WAIS) Block Design, WAIS Digit Symbol and WAIS Information tests. Of the 17 SNPs gen-
otyped in COGA in this region, we find one significantly associated with WAIS digit symbol
test results. This test captures aspects of reaction time and memory, suggesting that a phe-
notype relating to memory and learning may have been the driving force behind selection at
these loci. This study could begin to explain why these seemingly deleterious SNPs are
present at their current frequencies.
Introduction
Consequences of nicotine dependence are the leading cause of preventable death in the USA
and it has been noted that some populations experience higher levels of addiction than others
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[1] but the reason for this is not understood. Multiple studies have demonstrated a genetic
component to nicotine addiction [2–4], but little is known about the role of natural selection in
shaping the genetic components of nicotine addiction. Such knowledge could help us under-
stand the genetic and behavioral nature of addiction and ultimately facilitate the design and
delivery of appropriate interventions to reduce nicotine addiction.
It has been estimated that approximately 10% of the genome has been affected by linkage
due to recent selective sweeps [5]. However, it is challenging to make direct and clear inference
on the phenotypic that is the target of natural selection. This is particularly true when the phe-
notype being examined has no obvious evolutionary consequences, and has a disease or trait-
related association with no clear reproductive consequence today, but where patterns of genetic
variation are consistent with a positive selective sweep in recent human history. In this case,
additional mechanisms and/or alternative explanations must be sought for the existence of
selection on the gene of interest. An example of such a situation occurs in the gene encoding
hemoglobin. In homozygous form, the ‘sickle cell’ allele, HbS, drives the formation of mal-
formed red cells, which aggregate, blocking blood flow to numerous organs including the
brain. This results in organ damage and strokes, severely shortening the lifespan of the individ-
ual. Nonetheless, the HbS allele is maintained in the gene pool in regions where malaria is
endemic because in heterozygous form it provides protection against malaria (for a review see
[6]. The case of nicotine addiction represents a similar conundrum. Several genetic variants
that modify susceptibility to or protection from nicotine dependence have been identified by
genome-wide association studies (GWAS) [2,4,7]. Perhaps not surprisingly, the loci identified
in these studies mainly include genes encoding neuronal nicotinic cholinergic receptors
(CHRNs).
Neuronal cholinergic nicotinic receptors (CHRNs) are a heterogeneous class of cation (posi-
tively charged) channels expressed in the central and peripheral nervous system. There are 11
neuronal CHRN genes, each of which encodes a receptor subunit. The neuronally expressed
nicotinic receptors consist of combinations of alpha and beta subunits, encoded in humans by
8 alpha (α2-α 7, α9-α10) and 3 beta (β2-β4) genes [8]. These subunits form homo- or hetero-
pentameric subtypes, which are present in various regions throughout the nervous system. To
form a receptor, five subunits must be combined within the cell and the specific combination
of these subunits defines the receptor subtype.
In the body, the opening of these channels is controlled by the endogenous ligand, acetyl-
choline, a chemical produced by neurons to activate other nearby neurons. Nicotine, the major
psychoactive chemical present in tobacco smoke is a chemical present in the environment that
can also stimulate the opening of these nicotinic acetylcholine receptor ion channels [9]. A
number of GWAS studies have been performed that demonstrate an association between the
nicotinic receptors and smoking. The strongest association between nicotinic receptors and
nicotine addiction is a non-synonymous change (rs16969968, D398N) in the gene encoding
the α5 subunit of the nicotinic receptor (CHRNA5) on chromosome 15 [7,10–14]. When cells
are made to express nicotinic receptors containing the minor allele form of this SNP (398N),
agonists induce less channel opening and cell activation than in cells that express receptors
containing the major allele (398D) [11]. Thus, the minor allele at this SNP results in a signifi-
cant functional change in the behavior of this ion channel, causing more nicotine to be needed
in individuals with the minor allele to produce the same effect. Additionally, SNPs within the
chromosome 15 and chromosome 8 regions have been associated with alocohol and cocaine
dependence in addition to their associations with smoking related traits [15–17]. Although the
underlying functional mechanism underlying the associations at the nicotinic receptors on
chromosome 8 is not known, there is nevertheless a genome-wide significant signal with the
LD bin [18].
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determining the diagnosis, prognosis, and treatment
of addiction.
Here we test the hypothesis that natural selection has acted on these genes. But if the null
hypothesis of neutral evolution or demographic processes is rejected, why would nature seemingly
select for this trait, especially given the fact that it is believed that nicotine has not been a part of
our evolutionary history long enough, and in large enough quantities, for its effects to be visible in
our genomes? One hypothesis is that selection acted on another phenotype and the effect on nico-
tine addiction was secondary and incidental, a genetic phenomenon termed hitchhiking.
Nicotine is known to have an enhancing effect on cognitive performance. It enhances the
reorientation of attention in visuospatial tasks [19] and alters the neuronal activity responsible
for increased attention and arousal [20]. Furthermore, several studies have found associations
between SNPs in multiple nicotinic receptor genes and cognitive performance [21,22]. How-
ever, effects on cognitive performance at SNPs related to nicotine dependence seem peculiar
given the presumed acceleration in cognitive development over recent human history. There-
fore, these results suggest that if selection is shaping the genetic landscape of these genes, it
may be through their effect on cognitive function in the absence of drug use. Evidence from
nicotinic receptor knockout mice also supports a role for nicotinic receptors in memory and
learning, as well as anxiety levels. CHRNA7 knockout mice have impaired reaction times [23]
and decreased procedural learning [24], while, CHRNA6 knockout mice show that this receptor
plays a role in nicotinic modulation of dopaminergic transmission, an important component
of learning and memory [25]. Based on these observations, we hypothesize that at least some of
the nicotinic receptors may have been targets of recent selection and that this selection is
related to the role of nicotinic receptors in memory and learning.
To test this hypothesis, we use two summaries of genetic variation that have different statis-
tical power to make inferences, depending on the model of selection and associated population
demography. Two different methods were used for detecting natural selection at two loci rele-
vant to nicotine dependence, specifically the CHRNA5-A3-B4 region on chromosome 15q25
and the CHRNB3-A6 region on chromosome 8p11. We provide strong evidence for selection
in the CHRNB3-A6 region and moderate evidence for selection in the CHRNA5-A3-B4 region.
However, there is only a modest correlation between nicotine dependence and score on the
Wechsler Adult Intelligence Scale (WAIS) Digit Symbol test in our dataset. Overall, we suggest
that one possible explanation for these results is that SNPs in these regions associated with risk
of nicotine dependence are associated with natural selection acting at these loci to improve
human memory and learning.
Results
Tajima’s D Test
We calculated Tajima’s D over the regions of the nicotinic receptors on chromosomes 8 and
15, as well as lactase on chromosome 2 as the positive control. As the program utilized does not
incorporate ancestral information, all results are based on the folded frequency spectrum, i.e.
the distribution of polymorphic sites according to the number of chromosomes that carry a
given minor allele rather than the number of chromosomes that carry the derived, non-ances-
tral allele. [26]Fig 1 shows regional plots of the Tajima’s D values for the LCT, CHRNA5-A3-B4
nicotinic receptor gene region and the CHRNA6-B3 gene region. Within each of these regions,
we calculated sliding windows of 10 kb with an increment of 1 kb. We then compared the num-
ber of windows within each region with Tajima’s D values above 2 or below -2 (this represents
the 95% confidence interval of values in our data) to permutations of 10,000 randomly selected
regions of the same size across the genome.
We utilized the LCT gene region as a positive control. LCT encodes the protein lactase and
mutations in the region give rise to lactase persistence. The lactase persistence phenotype is
Selection at Nicotine Dependence Associated Loci
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due to changes in a regulatory region that enhances the expression of LCT located in intron 13
of the neighboring gene,MCM6 [27]. Fig 1A shows the distribution of Tajima’s D values in the
sliding windows in the LCT region in AFR, ASN and EUR. As expected, both the Asian and
European populations show many windows above 2 but very few exist in the African popula-
tion. All p-values are derived using permutations of 10,000 regions of the same size from across
the genome. For Europeans and Asians, the proportion of windows with extreme values was
8.6% and 6.5%, respectively (Table 1). This is highly significant in EUR, when compared to the
negative control regions, and modestly significant in ASN (<p = 2x10-7 and p = 0.01 for EUR
and ASN, respectively) and appears inconsistent with the null hypothesis of neutral evolution
and demography at the LCT locus especially in the EUR populations. In contrast, the histogram
for AFR shows few windows with extreme Tajima’s D values. Indeed, the proportion of win-
dows with extreme values was<1% and was not significantly different from the negative
Fig 1. Tajima’s D and iHS Results. A-CTajima’s D andD-F) iHS for the LCT region on chromosome 2, theCHRNA3-B4-A5 gene cluster on chromosome 15
and theCHRNB3-A6 gene cluster on chromosome 8 across individuals of European (red), African (Purple) or Asian (green) ancestry. Lines are the 95%
confidence intervals as calculated by permutation for iHS and Tajima’s D.
doi:10.1371/journal.pone.0134393.g001
Table 1. Summary of Extreme Tajima’s D and iHS Values in Each Region in Comparison with Negative Controls.
Gene(s) Pop # windows|TajD|>2 Proportion p-value # windows|iHS|>2 Proportion p-value
CHRNA5-A3-B4 EUR 173/1273 13.60% <2 x 10−16 1/181 <1% NS
ASN 91/1273 7.10% 4 x 10−4 3/224 1.3% NS
AFR 30/1294 2.30% NS 16/266 5.6% NS
CHRNB3-A6 EUR 13/1066 1.22% NS 26/110 23.6% 4 x 10−4
ASN 1/973 <1% NS 3/116 2.59% NS
AFR 23/1097 2.10% NS 93/357 26.1% 3 x 10−4
LCT/MCM6 EUR 98/1136 8.63% 2 x 10−7 111/138 80.4% < 1 x10-6
ASN 76/1161 6.55% 0.01 20/219 9.1% NS
AFR 5/1240 <1% NS 9/278 3.2% NS
Proportion of extreme Tajima’s D and his values in selected regions. P-values are produced by permutation of 10,000 randomly selected regions of the
same size across the genome.
doi:10.1371/journal.pone.0134393.t001
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controls, therefore we are unable to reject the null hypothesis of neutral evolution and demog-
raphy at this locus in AFR.
We next measured Tajima’s D in the CHRNA5-A3-B4 gene cluster on chromosome 15. In
this region, we analyzed a 120 kb region that includes the nicotinic receptor gene cluster as
well as ~18 kb upstream of CHRNA5. This was done to ensure that we included the large region
upstream of CHRNA5 that has been associated with regulation of the level of mRNA expression
for CHRNA5 [28]. Fig 1B shows the distribution of Tajima’s D values in the sliding windows in
the CHRNA5-A3-B4 region in AFR, ASN and EUR. Overall, we observed increased numbers of
sliding windows with extreme Tajima’s D values in each of the three populations, which is not
consistent with a neutral evolution and demography in this region (Table 1). Of note, several
SNPs previously shown to be associated with nicotine, alcohol and/or cocaine dependence [7,10–
14] are within regions with high Tajima’s D values. Additionally, within the EUR population,
these regions also harbor SNPs in an LD bin tagged by rs5887655 previously shown to be signifi-
cantly associated with CHRNA5mRNA expression in the brain [28]. Table 2 summarizes the
Tajima’s D values for windows containing associated SNPs in each of these two LD bins.
For the CHRNB3-A6 region, we examined a rather larger segment of the genome upstream
of the gene cluster. This was done in order to include several upstream SNPs that have previ-
ously been shown to exhibit associations with nicotine dependence or cocaine dependence
[17]. Fig 1C shows a regional plot of Tajima’s D values across the sliding windows in the
CHRNB3-A6 region. In AFR, there were several windows with extreme Tajima’s D values
upstream of CHRNB3 and in the intergenic region between CHRNB3 and CHRNA6. Among
the three populations tested, none showed a significant increase in the number of windows
with extreme Tajima’s D values when compared to the permutations. The concentration of
windows with extreme Tajima’s D values upstream of CHRNB3 is noteworthy in the context of
risk for nicotine addiction. Of note, a recent genome-wide association study found that a SNP
in this region, rs1451240, was associated with reduced risk for nicotine dependence, measured
using the Fagerstrom Test for Nicotine Dependence (FTND) [18]. The LD bin tagged by
rs1451240 spans ~66 kb and several other alleles of SNPs in this bin have been associated with
reduced risk for nicotine dependence, although no others are significant at the genome-wide
level [18]. The data in Table 3 show that in EUR and AFR, four adjacent SNPs from this LD
bin, including rs1451240, were present in sliding windows with extreme Tajima’s D values in
AFR. These data suggest that these nicotine dependence-associated SNPs may be undergoing
balancing selection or positive selection in these two populations.
Integrated Haplotype Score (iHS) Analyses
Fig 1 shows regional plots of iHS scores for the LCT, CHRNA5-A3-B4 nicotinic receptor gene
region and CHRNA6-B3 nicotinic receptor gene region. Within each of these regions, we calcu-
lated the iHS score for all SNPs for which we could unambiguously determine the chimp ances-
tral allele. We then compared the number of SNPs within each region with iHS values above 2
or below -2, to the 10,000 equally sized permutated regions that were chosen at random.
We again used the LCT/MCM6 region as a positive control. Fig 1D shows the regional plots
of iHS values in the LCT/MCM6 region for EUR, ASN and AFR populations. As expected, the
AFR population shows few extreme values (only 3.2%) and this does not differ significantly
from the negative control. In EUR and ASN, the overall average proportion of extreme values
for this region is 80.4% and 9.1%, respectively (Table 1). The clustering of extreme iHS values
in the genic areas of this region is consistent with what is known about large-scale positive
selection at this locus in the EUR population and to a lesser extent in the ASN population [27].
This demonstrates the validity of this approach for identifying genes undergoing selection.
Selection at Nicotine Dependence Associated Loci
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Fig 1E shows the histogram of iHS values across the CHRNA5-A3-B4 locus on chromosome
15. The summary statistics are given in Table 1. None of the three populations showed a pro-
portion of extreme iHS values that was significantly different than predicted by permutation.
In addition, none of the SNPs with extreme values included any of the SNPs previously found
to be associated with nicotine dependence (Table 2). The presence of a significant enrichment
of extreme Tajima’s D values in this region, however, suggests that if positive selection in this



















rs72740955 intergenic 0.37 (1.53, 2.07) -0.74 0.03 (0.72, 0.97) -1.25 0.09 (0.88, 1.00) 0.44
rs2036527 intergenic 0.37 (0.11, 0.11) -0.5 0.03 (-0.57, -0.54) -0.85 0.16 (-1.15, 0.20) 1.48
rs55853698 CHRNA5 5'UTR 0.37 (0.56, 1.93) -0.65 0.04 (-0.02, 1.00) -0.31 0.06 (0.24, 0.56) 1.05
rs17486195 CHRNA5 intronic 0.36 (1.59, 1.64) -0.62 0.03 (-0.17, 0.14) -0.82 0.11 (-0.10, -0.07) 0.48
rs17486278 CHRNA5 intronic 0.36 (0.39, 0.70) -0.62 0.31 (0.04, 0.60) -0.45 0.28 (0.42, 0.47) 0.72
rs72740964 CHRNA5 intronic 0.36 (0.78, 1.63) -0.73 0.03 (0.21, 0.98) -0.57 0.04 (0.08, 0.56) 0.14
rs951266 CHRNA5 intronic 0.36 (-0.22, 0.22) -0.65 0.03 (-0.84, -0.37) -0.5 0.08 (-0.89, -0.74) 0.91
rs16969968 CHRNA5 missense 0.36 (2.00, 2.33) -0.71 0.03 (0.43, 1.01) -0.44 0.02 (0.29, 0.62) -0.01
rs1051730 CHRNA3
synonymous
0.36 (1.40, 1.90) -0.64 0.03 (0.41, 0.78) -0.67 0.09 (-0.29, -0.23) 0.69
rs1317286 CHRNA3 intronic 0.36 (0.32, 1.27) -0.8 0.09 (2.00, 2.56) 0.78 0.24 (0.73, 1.36) -0.43
rs12914385 CHRNA3 intronic 0.4 (2.35, 2.55) -0.39 0.32 (1.85, 2.01) 0.36 0.2 (1.13, 1.35) 0.39
rs114205691 CHRNA3 intronic 0.64 (0.80, 1.65) 1.53 0.68 (0.00, 0.81) 0.15 0.8 (1.75, 1.97) 0.23
rs8040868 CHRNA3
synonymous
0.59 (0.87, 1.37) 1.54 0.62 (1.63, 2.17) 0.25 0.63 (-0.27, 0.13) 0.67
rs55958997 intergenic 0.39 (1.03, 1.66) -1.08 0.06 (0.74, 1.23) 0.23 0.3 (-0.41, -0.38) -0.45
rs72743158 CHRNB4 intronic 0.38 (0.26, 1.27) -0.79 0.02 (0.79, 1.34) -0.83 0.03 (0.20, 0.20) 1.11
rs55988292 CHRNB4 intronic 0.39 (-1.52, -0.24) -0.26 0.02 (-0.35, 028) -0.94 0.14 (-0.93, -0.61) -0.7
rs4275821 intergenic 0.33 (2.02, 2.32) -0.39 0.14 (0.61, 088) -0.02 0.18 (0.74, 0.99) -0.13
rs588765 CHRNA5 intronic 0.4 (2.18, 2.22) -0.32 0.15 (0.00–0.26) -0.2 0.25 (-0.30, -0.30) 0.44
rs6495306 CHRNA5 intronic 0.4 (2.07, 2.32) -0.32 0.15 (-0.42, 0.06) -0.2 0.26 (-0.16, 0.31) 0.41
rs495090 CHRNA5 intronic 0.35 (1.47, 2.06) -0.66 0.2 (1.17, 1.37) 0.48 0.4 (0.77, 1.23) 0.06
rs680244 CHRNA5 intronic 0.4 (-0.77, 0.83) -0.27 0.21 (-0.60, 0.24) 0.62 0.4 (-0.63, -0.06) -0.11
rs621849 CHRNA5 intronic 0.41 (0.36, 1.35) -0.27 0.21 (2.07, 2.08) 0.57 0.4 (0.47, 1.13) -0.21
rs11637635 CHRNA5 intronic 0.65 (1.61, 2.18) 1.51 0.86 (-0.28, -0.13) 0.99 0.78 (-0.60, -0.35) 0.35
rs481134 CHRNA5 intronic 0.6 (0.14, 0.77) 1.1 0.85 (-0.48, 0.19) 1.06 0.75 (-0.87, -0.61) 0.19
rs555018 CHRNA5 intronic 0.4 (-0.84, 0.78) -0.22 0.15 (-0.39, 0.04) 0.01 0.26 (-0.77, -0.23) 0.97
rs647041 CHRNA5 intronic 0.4 (-1.06, -0.14) -0.24 0.18 (-1.05, 0.03) 0.24 0.24 (-1.08, -0.60) 0.77
rs615470 CHRNA5 3' UTR 0.65 (2.54, 2.57) 1.46 0.83 (-1.20, -0.75) 0.66 0.67 (-1.09, -0.60) -0.08
rs6495307 CHRNA3 intronic 0.6 (-1.17, 0.14) 0.96 0.82 (0.55, 0.84) 0.71 0.66 (-0.83, -0.41) -0.07
rs62010327 CHRNA3 intronic 0.35 (0.15, 1.60) -0.74 0.14 (0.42, 0.85) -0.78 0.08 (0.65, 0.97) -0.99
rs12901300 CHRNA3 intronic 0.4 (-1.37, -0.26) -0.3 0.19 (-0.71, 0.11) 0.26 0.34 (-0.47, 0.32) 0.91
rs3743077 CHRNA3 intronic 0.4 (1.86, 2.62) -0.27 0.18 (-0.25, 0.14) 0.34 0.11 (-0.96, -0.77) 0.33
rs62010328 CHRNA3 intronic 0.34 (1.86, 1.90) -0.8 0.14 (-0.54, -0.25) -0.69 0.07 (-1.17, -0.96) -0.54
rs2869546 CHRNA3 intronic 0.36 (2.08, 2.40) -0.18 0.18 (2.31, 2.63) -0.09 0.29 (3.17, 3.41) 0.66
rs4366683 CHRNA3 intronic 0.54 (-0.72, 0.13) 0.44 0.45 (1.50, 2.00) -0.96 0.5 (0.70, 1.54) 0.02
rs58643100 CHRNA3 intronic 0.46 (-0.72, 0.13) 0.63 0.26 (1.50, 2.00) 0.84 0.41 (0.70, 1.54) 0.24
All SNPs have r2 value of 0.8 or greater with rs16969968 or rs588765. Signiﬁcant values and SNP names are bolded.
doi:10.1371/journal.pone.0134393.t002
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region occurred, it may have occurred long enough ago such that the long haplotypes required
for iHS have broken down by recombination.
Fig 1F shows a histogram of the iHS values for the CHRNB3-A6 cluster on chromosome 8.
Summary statistics are shown in Table 1. Both the AFR and EUR populations show an excess
of extreme iHS values (26.1% and 23.6%, respectively). By contrast, in the ASN population,
there were few windows of extreme iHS scores and the overall proportion was not significantly
different from the negative control. Several SNPs with extreme iHS values in these populations
are contained within bins previously shown to be associated with either nicotine or cocaine


















rs1979140 intergenic 0.77 (-0.75, -0.34) -1.44 0.82 (-1.21, -1.15) -0.47 0.28 (-1.26, -0.99) -0.15
rs7816726 intergenic 0.77 (0.33, 1.00) -1.44 0.81 (-0.02, 0.70) -0.49 0.28 (0.08, 0.17) -0.56
rs10958726 intergenic 0.23 (0.1, 0.68) 2.46 0.18 (-0.85, -0.15) 1.06 0.63 (-0.70, 0.18) 0.65
rs7842601 intergenic 0.23 (0.17, 0.62) 2.58 0.18 (-0.33, -0.17) 1.06 0.63 (0.63, 1.33) 0.84
rs13273442 intergenic 0.23 (-0.39, 0.69) 2.32 0.18 (-0.60, -0.45) 1.02 0.63 (-0.75, 0.04) -0.21
rs9792277 intergenic 0.77 (1.56, 1.80) -1.45 0.81 (1.06, 1.17) -0.54 0.33 (1.38, 2.32) 0.77
rs1451239 intergenic 0.77 (2.41, 2.58) -1.45 0.82 (1.34, 1.40) -0.46 0.34 (2.18, 2.51) 0.89
rs1451240 intergenic 0.23 (2.41, 2.54) 2.48 0.18 (1.33, 1.41) 1.11 0.67 (2.18, 2.46) 0.09
rs1901281 intergenic 0.77 (2.37, 2.68) -1.56 0.81 (1.26, 1.33) -0.54 0.28 (2.18, 2.19) 0.37
rs4736835 intergenic 0.23 (2.48, 2.68) 2.6 0.18 (1.17, 1.26) 1.11 0.66 (1.47, 2.63) -0.08
rs1955185 intergenic 0.77 (1.49, 1.67) -1.58 0.82 (0.64, 0.69) -0.52 0.28 (1.08, 1.59) 0.54
rs13277254 intergenic 0.23 (0.89, 1.27) 2.69 0.18 (0.64, 0.97) 1.32 0.63 (1.11, 1.29) -0.6
rs13277524 intergenic 0.77 (0.64, 0.89) -1.63 0.82 (0.24, 0.97) -0.65 0.28 (0.43, 1.29) 0.61
rs6474412 intergenic 0.77 (1.09, 1.43) -1.63 0.82 (0.53, 0.66) -0.65 0.34 (1.01, 1.49) 1.25
rs6474413 intergenic 0.77 (1.86, 2.19) -1.66 0.82 (0.13, 0.22) -0.65 0.28 (1.15, 1.33) 0.62
rs7004381 intergenic 0.23 (0.68, 1.86) 2.72 0.18 (-0.15, 0.22) 1.32 0.63 (0.29, 1.15) -0.72
rs6985052 intergenic 0.77 (-0.37, 0.68) -1.66 0.82 (-0.85, -0.16) -0.65 0.29 (-1.04, -0.29) 0.71
rs4950 CHRNB3
5'UTR
0.23 (-0.39, 0.12) 2.71 0.18 (-0.44, -0.16) 1.31 0.8 (0.38, 1.55) 0.25
rs9643891 CHRNB3
intronic
0.77 (-0.34, 0.13) -1.85 0.82 (0.60, 0.72) -1.01 0.15 (-0.65, -0.16) -0.15
rs9643853 CHRNB3
intronic
0.77 (-1.04, -0.34) -1.89 0.82 (-0.60, 0.60) -1.01 0.15 (-1.55, -0.65) -0.1
rs13280604 CHRNB3
intronic
0.23 (0.47, 1.68) 2.9 0.18 (0.07, 0.50) 1.94 0.8 (0.04, 0.83) 0.12
rs6997909 CHRNB3
intronic
0.77 (0.70, 0.70) -1.88 0.82 (-0.25, 0.11) -1.19 0.15 (-1.00, -1.00) 0
rs6474414 CHRNB3
intronic
0.77 (0.40, 0.40) -1.88 0.82 (-0.60, -0.21) -1.19 0.15 (-0.76, -0.12) 0
rs6474415 CHRNB3
intronic
0.23 (1.26, 1.35) 3.07 0.18 (-0.12, 0.22) 1.97 0.85 (-0.85, -0.52) 0.84
rs4236926 CHRNB3
intronic
0.77 (-0.04, -0.03) -1.71 0.81 (-0.14, -0.11) -1.41 0.15 (-0.54, -0.54) 0.14
rs16891561 CHRNB3
intronic
0.77 (-1.28, -0.90) -1.67 0.81 (-0.89, 0.72) -1.26 0.15 (-1.08, -0.48) 0.2
rs55828312 CHRNB3
intronic
0.24 (-(0.89, -0.74) 2.86 0.19 (-1.13, -0.31) 2.13 0.83 (-0.85, 0.67) 1.12
All SNPs have r2 value of 0.8 or greater with rs1451240. Signiﬁcant values and SNP names are bolded.
doi:10.1371/journal.pone.0134393.t003
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dependence phenotypes [17,18]. Table 3 lists the SNPs from the LD bin showing genome-wide
significance for reduced risk for nicotine dependence and provides the iHS value for
rs1451240, the tag SNP. While there are several extreme values in AFR in the middle of this
gene cluster, these values do not overlap with known SNPs related to nicotine dependence in
this region. In EUR, 13 SNPs in this LD bin, including the tag SNP rs1451240, have extreme
iHS values. All have positive values, indicating the presence of unusually long haplotypes con-
taining the ancestral allele suggesting that the ancestral allele, which is associated with a greater
risk of nicotine dependence is being favored by selection. An LD bin in the CHRNB3-A6 region
bin that has been shown to have SNPs significantly associated with increased risk for cocaine
dependence [17] also contained an abundance of SNPs with extreme iHS values (S1 Table).
This bin is fairly large and spans the entire CHRNB3-A6 cluster. It contains rs4952 and rs4953,
two low frequency synonymous variants in CHRNB3 that have previously been reported to be
associated with lower risk for nicotine dependence [10]. All SNPs in the bin are present at
around 10% in AFR and 4% in EUR but absent in ASN, possibly explaining the lack of extreme
iHS values in the ASN population. Overall, 40% of the SNPs in this bin showed extreme values
in AFR and 15% of the SNPs in this bin showed extreme values in EUR. As these SNPs are
absent from the ASN population, none showed extreme iHS values. The dense clustering of
extreme iHS values in AFR and EUR is rarely expected under a neutral model, and is consistent
with the hypothesis of the action of recent selection. In EUR, all of the SNPs in this LD bin
with extreme iHS values had positive values and all were shared with AFR. Thus, in both popu-
lations, the ancestral allele associated with increased risk for nicotine dependence and
decreased risk for cocaine addiction is being favored.
Nicotine addiction and cognitive function
The Tajima’s D analysis and integrated haplotype score both indicate that the CHRNB3-A6
cluster is undergoing selection and in particular, the iHS scores suggest that it is the risk allele
for nicotine dependence on chromosome 8 that is under positive selection. As it seems unlikely
that risk for nicotine dependence is the phenotype undergoing selection, and because nicotinic
receptors are involved in memory and learning, we hypothesized that a phenotype related to
memory or learning, such as attention, might be the phenotype being selected.
To test this possibility, we obtained genotype and cognitive phenotype data from the Collab-
orative Study of the Genetics of Alcoholism (COGA). Using this dataset, we tested the associa-
tion between genotypes and three of the most relevant phenotypes, namely scores on the
Wechsler Adult Intelligence Scale (WAIS) Block Design, WAIS Digit Symbol andWAIS Infor-
mation tests. These tests were designed to measure aspects of perceptual organization, process-
ing speed and verbal comprehension, respectively [29].
Table 4 summarizes our findings for the top SNPs associated with WAIS Digit Symbol test.
No other neurocognitive phenotypes besides WAIS digit symbol had SNPs with significant val-
ues in the CHRNB3-A6 region and none of the three neurocognitive phenotypes had a signifi-
cant association with SNPs in the region of CHRNA5-A3-B4 on chromosome 15 (not shown).
Of the 17 SNPs in the CHRNB3-A6 region on chromosome 8, one SNP–rs7017612—passed
multiple test correction (p0.003) for association with the score on the WAIS Digit Symbol
test (β = 0.43, p = 0.003). rs7017612 lies in the intergenic region between CHRNB3 and
CHRNA6. This SNP is highly correlated with rs6474413 (r2 = 0.75; D’ = 0.95), a SNP tagging
the genome-wide significant bin for decreased risk for nicotine dependence. These data suggest
a modest association between genotype at these SNPs one measure of cognitive function.
A second SNP in the CHRNB3-A6 region–rs6982753- had a nominal p-value with the
WAIS Digit Symbol phenotype before multiple test correction and almost passed the multiple
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test correction (p = 0.009). Interestingly, this SNP has an r2 of 0.91 with rs892413 (β = 0.39,
p = 0.008), a SNP that has previously been associated with increased risk for cocaine depen-
dence [17].
Discussion
Many studies have demonstrated that risk for nicotine addiction has a genetic component. We
performed two tests of selection on chromosomal regions containing the genes encoding five
nicotinic receptor subunits and each of these analyses indicate that selection likely occurred at
the CHRNB3-A6 locus. Both the Tajima’s D test and iHS point to an ongoing sweep in humans
on chromosome 8. In the case of the CHRNB3-A6 locus, all of the extreme values in the Taji-
ma’s D analysis were positive. High positive Tajima’s D values occur when there is an excess of
variants in a region with intermediate allele frequencies. This can occur in either balancing
selection or ongoing positive selection. We also found extreme iHS values in the CHRNB3-A6
locus. This region fulfills the criteria for a sweep laid out by Voight and colleagues [30], i.e.
clustering of extreme iHS values. Extreme values of iHS are unlikely under simple demographic
models, and thus can indicate the action of an ongoing selective sweep. Despite the fact that
none of the populations had significantly different p-values from the negative control in the
chromosome 8 region, a few key SNPs did have extreme values. Together, these data imply that
the Tajima’s D analysis is picking up on ongoing positive selection rather than balancing
selection.
Several SNPs in the CHRNB3-A6 locus on chromosome 8 have previously been associated
with a decreased risk of nicotine dependence [18]. One of these, rs1451240, was present in a
window that showed extreme values in both the Tajima’s D test and iHS. The extreme positive
Table 4. Association results with SNPs in CHRNB3-A6 region and Scores on theWAIS Digit Symbol
test.
SNP β SE p-value
rs7017612 0.43 0.19 0.003
rs6982753 0.39 0.20 0.009
rs10958725 0.25 0.18 0.035
rs13273442 0.28 0.18 0.036
rs4950 0.24 0.18 0.038
rs1530848 0.24 0.18 0.038
rs6474413 0.25 0.18 0.038
rs10107450 0.10 0.19 0.064
rs16891620 0.27 0.25 0.066
rs2196128 0.22 0.20 0.066
rs1530847 0.23 0.20 0.104
rs16891530 0.19 0.42 0.414
rs4952 0.19 0.42 0.414
rs7815274 0.19 0.42 0.426
rs10109429 0.07 0.31 0.494
rs13270610 -0.16 0.35 0.632
rs16891604 0.23 0.42 0.826
Beta, Standard Error (SE), and P-value for all SNPs in the CHRNB3-A6 region of the COGA family GWAS
and their association with scores on the WAIS Digit Symbol test. Covariates used were age, sex and FTND
score. For all tests, 492 individuals were used for the association test.
doi:10.1371/journal.pone.0134393.t004
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iHS value in the window including rs1451240 indicates that the haplotype containing the
ancestral allele is being positively selected. As the derived allele provides protection from nico-
tine addiction, this suggests that it is the allele that is associated with a greater risk of nicotine
dependence that is being selected. Since highly concentrated sources of nicotine were not pres-
ent in the ancestral environment, it seems likely that this phenotype of nicotine dependence
would have hitchhiked along with a more beneficial phenotype. One challenge with this region
is that it is approximately 1,500,000 bp away from the centromere of chromosome 8. This
could be affecting the results by some unknown mechanism. However, the region including the
nicotinic receptors on chromosome 8 was among the top 5% of iHS scores among all regions
tested in the genome.
Selective pressures in our ancestral environments were likely not on addiction, but rather on
behaviors that were biologically rewarding (i.e. mate or food finding, avoidance of harmful sti-
muli). Given the role of nicotine in neurological function, it is possible that, in the case of nico-
tine addiction, the phenotype on which natural selection was working was related to
enhancements in memory or cognition. The addiction phenotype would have hitchhiked along
because it acts through the same or related mechanisms. The addiction phenotype was likely
not selected against in ancestral environments because the availability and opportunity for pro-
longed use of purified drugs was negligible.
To test this possibility, we assessed the association of SNPs in the CHRNB3-A6 locus with
scores on WAIS tests of memory and cognitive function. Our analysis of the individuals in the
COGA dataset suggests that one SNP, rs7017612, which lies in the intergenic region between
CHRNB3 and CHRNA6, is associated with increased score on the WAIS Digit Symbol test.
This test is thought to largely measure processing speed, but also, to some extent, memory.
rs7017612 itself has not been reported to be associated with nicotine dependence. However, it
is in moderately high LD (r2 = 0.75) with rs6474413, a SNP tagging the genome-wide signifi-
cant bin for decreased risk for nicotine dependence. Thus, our data are consistent with the pos-
sibility that improved performance on this particular cognitive test is modestly associated with
a decreased risk for nicotine dependence and that alleles of SNPs in these regions have effects
on a subset of cognitive pathways best captured here by the WAIS digit symbol test. It is possi-
ble, however, that a function other than addiction or cognition is the true phenotype undergo-
ing natural selection at these loci.
Genetic studies of nicotine addiction have identified an inverse relationship between the
risk for nicotine addiction and the risk for cocaine addiction. For instance, the minor allele of
rs16969968, a missense variant in CHRNA5, increases risk for the development of nicotine
dependence, and independently decreases risk for cocaine dependence [15]. One hypothesis
would be that the true underlying selective pressure is on cocaine related phenotypes or a char-
acteristic that affects cocaine related reward pathways in the brain and that the alleles’ effect on
nicotine dependence is merely an accidental consequence. However, caution must be used
when interpreting this information, given that all drugs of addiction similarly affect the dopa-
minergic reward pathways.
Another alternative hypothesis is that the selective pressure at this locus was on social
behavior. Cocaine addiction is characterized by a dampened reward response to social interac-
tion, meaning that it inhibits the positive emotions that accompany social interaction or feel-
ings of belonging. A recent study demonstrated that cocaine users process social gaze (joint
attention on an object) differently than controls, resulting in a reduced activation of the reward
system during social interactions [31]. Using fMRI, these authors showed that cocaine users
had decreased activation of the medial orbitofrontal cortex, a region of the brain central for
reward processing. If alleles that alter cocaine dependence risk alter an individuals’ natural
reward system during social interactions, these observations could explain why alleles that
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protect against cocaine dependence could have provided advantage to carriers in the ancestral
environment. Since nicotine sensitizes the animal to the effects of cocaine, which blunts the
reward of social interactions, alleles that reduced the ability of nicotine to enhance the effects of
cocaine would have undergone positive selection. In this scenario, the nicotine and cocaine
dependence phenotypes are not hitchhiking with memory or learning, but rather with pheno-
types protecting against antisocial and therefore maladaptive behavior.
There was also moderate evidence for selection at the CHRNA5-A3-B4 locus. In particular,
rs16969968, the SNP that encodes the missense mutation in α5, that is strongly associated with
risk of nicotine dependence, lies in a sliding window exhibiting a high Tajima’s D score. The
iHS analysis of this locus did not provide evidence for selection. This could indicate that the
selective pressure exerted on this locus is older that that seen for the CHRNB3-A6 locus and as
such has allowed extended haplotypes to be broken down by recombination. In this scenario,
Tajima’s D would still be extreme while iHS scores in the region might be less so. This may be
particularly true if the selective pressure being exerted on the CHRNB3-A6 locus is ongoing.
Here we have used two statistical tests of selection and uncovered evidence of positive selec-
tion at the nicotinic receptors on chromosome 8 chromosome 15. Multiple drug-related phe-
notypes are associated with SNPs in or near these loci, however for several reasons it is unlikely
that these phenotypes are the direct targets of this selective pressure. We have proposed two
possible explanations 1) phenotypes related to memory and learning and 2) phenotypes related
to social behavior. We were only able to discover a modest association with memory-related
phenotypes, likely due to the small sample size. We also are as of yet unable to test this second
hypothesis because we do not have data in our sample for a phenotype measuring sociality.
However this work is the first to explicitly describe signs of natural selection acting on loci
underlying substance dependence phenotypes.
Materials and Methods
To determine whether the nicotinic receptor loci are under selection, we used Tajima’s D, and
integrated haplotype score (iHS) to examine the landscape of natural selection at three loci pre-
viously demonstrated to harbor genetic variants contributing to the risk of nicotine depen-
dence. These tests have different but complementary strengths. Tajima’s D test functions best
on recently completed selective sweeps. There are many variables that contribute to how far in
the past a sweep can be detected, such as how extreme the sweep was in the first place. Both the
mutation rate and the recombination rate affect it as well and vary widely across the genome
making generalizations difficult. By contrast, integrated haplotype score iHS functions best for
detecting sweeps in progress with alleles at intermediate frequencies, mainly in the range of or
after the separation of European, Asian and African populations, during the agricultural phase
of human evolution.
We utilized 1000 Genomes data for these analyses. Data was obtained from the 1000
genomes website (http://www.1000genomes.org/data), a third party source for population
whole genome sequence data. The populations were grouped into EUR (GBR, TSI, CEU, FIN),
ASN (CHS, CHB, JPT), and AFR (YRI, LWK, ASW). All methods were calculated for the same
regions: the CHRNA5-A3-B4 region on chromosome 15q25, the CHRNB3-A6 region on chro-
mosome 8p11, the LCT region as a positive control on chromosome 2q21, and ten intergenic
negative control regions where applicable.
Tajima’s D test
Tajima's D is a method of addressing the frequencies of variant sites, based on the expectation
that under neutrality, different estimates of expected diversity (θ) should be equal. Tajima’s D
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tests for a skew in the frequency spectrum by comparing two estimates of θ – the number of
segregating sites (S), and pairwise nucleotide diversity (π) [32]. Extreme positive values can
indicate either balancing selection or population subdivision, and extreme negative values can
indicate positive selection or population growth [33]. If the same skew is detected across the
genome, the effect is likely due to demography, whereas if the skew is localized to a few loci,
selection is more likely to be occurring.
In a review, Garrigan & Hammer [34] have combined published data for Tajima’s D values
from 65 autosomal loci. They find the mean value for Africans is slightly negative (-0.20) and
for non-Africans is slightly positive (0.13). Overall, the values range from approximately -2 to
2. As such, we have taken Tajima’s D values above 2 or below -2 to count as extreme values, as
this represents the 95% confidence interval of values in our data.
Tajima’s D was calculated using the program Variscan [35]. After an exploratory data analy-
sis of window size, we used a sliding window size of 1000 bp, and window increments of 100 bp
for the analysis. Smaller window sizes resulted in too few SNPs in a window to calculate Taji-
ma’s D, while larger windows made it much harder to narrow down specific SNPs that may be
the ultimate target of selection. Variscan outputs a file giving the Tajima’s D value for every
window of the specified bp size on the sliding scale [35]. These values were then superimposed
onto graphs of the regions.
Integrated Haplotype Score
iHS is a measure of whether a SNP is on an unusually long haplotype carrying the ancestral or
derived allele. It compares the rate of haplotype decay between haplotypes carrying either the
ancestral or derived allele at a given site, referred to as the core SNP. Haplotypes whose core
SNP is under selection will be unusually long compared to those evolving neutrally. Long hap-
lotypes with derived alleles are indicated by negative iHS values and those with ancestral alleles
are indicated by positive iHS values. Under neutrality, extreme scores are distributed through-
out the genome, however under selection, they are clustered across the selected region [30].
iHS is a good method for detecting directional selection, especially in a sweep that is in its early
phases. We used the programWHAMM to calculate this statistic [30].
The haplotype decay is calculated until the extended haplotype homozygosity (EHH)
reaches 0.05. EHH is defined as “the probability that two randomly chosen chromosomes car-
rying the core haplotype of interest are identical by descent for the entire interval from the core
region to point x” [36] (p. 833). Long haplotypes with derived alleles are indicated by negative
iHS values and those with ancestral alleles are indicated by positive iHS values. Under neutral-
ity, extreme scores are distributed throughout the genome, however under selection, they are
clustered across the selected region [30].
First, we extracted the desired regions from the 1000 Genomes dataset. We then selected
known SNPs within each region, and extracted a region of plus or minus 2000 SNPs around
that SNP, except in the case of CHRNB3-A6 where we selected plus or minus 2500 SNPs. We
constructed recombination maps using cM maps provided by the SHAPEIT2 program [37].
Ancestral alleles were determined using the latest version of Seattleseq (http://snp.gs.
washington.edu/SeattleSeqAnnotation137/). Phased haplotypes were coded as number of cop-
ies of the derived allele. All positions in which the derived allele could not be determined
unambiguously (i.e. C/G or A/T SNPs) as well as those without known chimp alleles were
removed from further analyses. All analyses were run on each population separately. As iHS is
greatly influenced by SNP allele frequency, iHS values fromWHAMMwere standardized
using the average and standard deviation of all SNPs on chromosome 15 and 8 binned by allele
frequency such that the average iHS value for each bin after standardization was identical. We
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excluded SNPs with a minor allele frequency less than 5% because low frequency SNPs are dif-
ficult to normalize accurately. After removing these SNPs, extracting just the desired gene
regions, and removing those with MAF of<0.05, there were ~150–350 SNPs per region,
depending on the population. Standardization was done separately for each population using
population specific averages and standard deviations. iHS values were then superimposed onto
graphs of the regions.
The haplotype on which a beneficial allele resides tends to be significantly longer than the
other haplotypes at the same frequency in the population when adjusted for the recombination
background. However, long haplotypes tend to occur in regions with low recombination, and
these can be confused with genuine genomic signals of positive selection [38]. This is why
WHAMM attempts to control for recombination by requiring the input of a cM map. The map
we used here was the cM map for imputation available on the website for the program
SHAPEIT2.
Candidate regions of positive selection were defined as genomic regions containing an
uncharacteristic clustering of SNPs with high iHS statistics. This was quantified as the propor-
tion of SNPs with |iHS|> 2 in the four regions of interest. Candidate regions of positive selec-
tion were identified as containing any SNP with an iHS score of |iHS|> 2, as this corresponds
to the top ~5% of all scores. The iHS value at a SNP “measures the strength of evidence for
selection acting at or near that SNP” however does not provide a formal significance test
(Voight et al. 2006).
Association Analyses
COGA recruited subjects in Hartford, Connecticut; Indianapolis, Indiana; Iowa City, Iowa;
New York City, New York; San Diego, California; St Louis, Missouri; and Washington, DC.
For inclusion in SAGE, cases had to meet lifetime criteria for DSM-IV alcohol dependence, the
majority of cases were recruited from alcoholism treatment centers. Control subjects, were
both biologically unrelated to cases, and had consumed alcohol but never experienced any sig-
nificant alcohol or drug-related problems, according to the Semi-Structured Assessment for
the Genetics of Alcoholism (SSAGA) [18]. The COGA sample utilized in this study consisted
of family GWAS data from 2102 European-Americans [14]. De-identified data from the Col-
laborative Studies on the Genetics of Alcoholism (COGA) were used. All participants in
COGA provided written informed consent for genetic studies and agreed to share their DNA
and phenotypic information for research purposes. The Washington University Human
Research Protection Office granted approval for data to be used for this study.
COGA administered a variety of neuropsychological tests to its subjects including the three
used here: Wechsler Adult Intelligence Scale-Revised (WAIS-R) Block Design, WAIS Digit
Symbol, and WAIS Information. In total there were 1247 European-Americans with these
neuropsychological phenotypes. However, the overlap between this number and those with
family GWAS data was 492. Therefore, our analyses were performed on 492 subjects. In WAIS
Block Design, the subject replicates models or pictures of two-color designs with blocks. In
WAIS Information, the subject answers a series of questions about factual information. In
WAIS Digit Symbol, the subject writes down as quickly as possible the symbols that correspond
to a series of numbers.
SNPs in the region of the nicotinic receptor clusters on chromosomes 8 and 15 were tested
for association with the scaled scores of neuropsychological phenotypes in European-Ameri-
cans from the COGA study using an additive linear mixed effects (LME) model with the lme-
pack.batch function as implemented in the GWAF package in R using age, sex and FTND
score as covariates [39]. Neither alcohol nor cocaine symptom count were significant covariates
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in the analysis and were thus not included in the analysis. The GWAF package enables associa-
tion testing with the ability to include individuals from families by correcting for relatedness
specified in a pedigree file.
Supporting Information
S1 Table. Tajima’s D and iHS values for SNPs correlated with rs9298626 within the
CHRNB3-A6 region. All SNPs were highly correlated (r2>0.9) with the SNP rs9298626.
(PDF)
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